Patient‐reported motor chemotherapy‐induced peripheral neuropathy impacts function in advanced colorectal cancer survivors receiving chemotherapy: A cross‐sectional study

• DOI: 10.1111/jjns.12531
• Publication Date: 2023-03-24T09:48:35Z
• Authors: Chia‐Fen Hsieh; Ya‐Ning Chan; Chih‐Jung Wu; Li‐Yu Yen; Yu‐Chi Chang; Ya‐Jung Wang
• Keywords: Chemotherapy-Induced Peripheral Neuropathy; Cross-sectional study

Chemotherapy-induced peripheral neuropathy limits cancer survivors' compliance with chemotherapy and impaired function. This study aimed to examine separate impacts of clinician-assessed, patient-reported sensory motor chemotherapy-induced on physical/role function functional interference in advanced colorectal survivors receiving chemotherapy.A cross-sectional, correlational design utilizing convenience sampling enrolled 75 stage III or IV adults undergoing chemotherapy. Participants filled out the Patient Neurotoxicity Questionnaire, Identification Pain Peripheral Neuropathy Scale. Then, a trained research nurse conducted brief neurological assessment using Total Scale - clinical version.The prevalence was from 34.7% 54.7% 16.0% 17.3%, respectively. Further, 20% participants suffered neuropathic pain. A low correlation between clinician-assessed detected. The significantly impacted by neuropathy.This superior valid tools measure neuropathy. Moreover, identification symptoms has largest influence survivors. Nurses may use easily administered settings for effective screening early detection prevent decline However, this still limited because cross-sectional design, small sample size, heterogeneity, recruiting only one medical center.